Free Trial

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies logo
$76.44 -1.52 (-1.95%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$76.71 +0.27 (+0.35%)
As of 09/12/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
2
Buy
9

Based on 11 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 2 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$88.40
15.65% Upside
According to the 11 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $88.40. The highest price target for GEHC is $103.00, while the lowest price target for GEHC is $73.00. The average price target represents a forecasted upside of 15.65% from the current price of $76.44.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

TypeCurrent Forecast
9/13/24 to 9/13/25
1 Month Ago
8/14/24 to 8/14/25
3 Months Ago
6/15/24 to 6/15/25
1 Year Ago
9/14/23 to 9/13/24
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
Hold
2 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$88.40$88.55$88.27$94.58
Forecasted Upside15.65% Upside20.21% Upside22.18% Upside8.83% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GE HealthCare Technologies Stock vs. The Competition

TypeGE HealthCare TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.91
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside15.65% Upside17,489.59% Upside10.72% Upside
News Sentiment Rating
Positive News

See Recent GEHC News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/28/2025Zacks Research
0 of 5 stars
 UpgradeHoldStrong-Buy
7/31/2025Citigroup
2 of 5 stars
Joanne Wuensch
Joanne Wuensch
4 of 5 stars
Boost TargetBuy$89.00 ➝ $93.00+30.40%
7/31/2025Morgan Stanley
3 of 5 stars
Patrick Wood
Not Rated
Lower TargetEqual Weight$78.00 ➝ $74.00+3.21%
7/14/2025BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
5/5/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSellNeutral$74.00 ➝ $73.00+3.50%
5/1/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$94.00 ➝ $82.00+19.42%
5/1/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$103.00 ➝ $89.00+29.06%
5/1/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$96.00 ➝ $85.00+22.20%
4/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOverweight$104.00 ➝ $88.00+35.41%
1/8/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy$95.00 ➝ $103.00+23.55%
9/30/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$100.00 ➝ $102.00+10.88%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageNeutral$90.00+5.77%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
5/1/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetNeutral$94.00 ➝ $86.00+10.45%
5/1/2024Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$110.00 ➝ $105.00+35.45%
4/1/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$80.00 ➝ $110.00+22.82%
2/15/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:26 PM ET.


Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 11, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • The current stock price is around $74, which is significantly lower than its 52-week high of $94.80, indicating potential for price appreciation.
  • The company reported a strong earnings per share (EPS) of $1.06 for the latest quarter, surpassing analysts' expectations, which reflects robust financial performance.
  • GE HealthCare Technologies Inc. has a solid return on equity of 23.93%, indicating effective management and profitability relative to shareholder equity.
  • The firm has a market capitalization of $35.61 billion, suggesting it is a well-established player in the healthcare technology sector, which can provide stability to investors.
  • Analysts have a consensus rating of "Moderate Buy" with an average price target of $88.40, indicating positive sentiment and potential for future growth.

GE HealthCare Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • The company has a debt-to-equity ratio of 0.85, which, while manageable, indicates that it has a significant amount of debt compared to equity, potentially increasing financial risk.
  • The PEG ratio of 3.01 suggests that the stock may be overvalued relative to its earnings growth, which could deter value-focused investors.
  • Despite a positive revenue growth of 3.5% year-over-year, the growth rate may not be sufficient to attract aggressive growth investors.
  • With a quick ratio of 0.93, the company may face challenges in meeting short-term liabilities, which could raise concerns about liquidity.
  • Recent analyst downgrades, such as Morgan Stanley lowering their price objective, may indicate a lack of confidence in the stock's near-term performance.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $88.40, with a high forecast of $103.00 and a low forecast of $73.00.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 2 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 15.65% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade by analysts.

GE HealthCare Technologies has been rated by research analysts at BTIG Research, Citigroup, Morgan Stanley, and Zacks Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.91 while the average consensus rating score for "medical" companies is 2.78. Learn more on how GEHC compares to other companies.


This page (NASDAQ:GEHC) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners